[1]
H. A. ODHAR, A. F. HASHIM, S. W. AHJEL, and S. S. HUMADI, “VIRTUAL SCREENING OF FDA-APPROVED DRUGS BY MOLECULAR DOCKING AND DYNAMICS SIMULATION TO RECOGNIZE POTENTIAL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS ENOYL-ACYL CARRIER PROTEIN REDUCTASE ENZYME”, Int J App Pharm, vol. 16, no. 1, pp. 261–266, Jan. 2024.